CCL4 and neoplasm: To characterize the mechanism of failed recruitment of the CD103+ DCs, the investigators analyzed the gene expression of these two tumor types and found that four chemokines (CCL3, CXCL1, CXCL2, and CCL4) were lower in the non-T-cell inflamed BRAF/PTEN/Bcat-STA tumors.